Today’s ONE Life Sciences Summit in #Aberdeen , created by The Times and The Sunday Times Scotland and #ONEBioHub , brings together #lifesciences leaders from across the UK with an audience of 150 professionals.
Stella Peace from Innovate UK opens with the keynote speech.
#timeslifesciencessummit
A. Sinclair Dunlop, Sarah Hardy, Andrew McNeill, Clare Terlouw and Gillian Bowditch, discussed what investors are looking for from #lifesciences entrepreneurs.
#timeslifesciencessummit
What makes a successful investee-investor relationship? Dr Poonam Malik| MBA FRSE FRSB and Stuart Hannah discussed with Ben Carter from Deepbridge Capital on their investee-investor journey.
#timeslifesciencessummit #lifesciences
Professor Andrew Porter, Dr Abdo Alnabulsi, Marcus Wischik, David Tudor and Ernst van Orsouw discussed strategies for commercialisation.
A good exit? Financial return, sticky supply chain, jobs and skills = sustainable, high-value sector.
#timeslifesciencessummit #lifesciences
Professor Caroline Barelle CEO and Founder of
Elasmogen and Lucy Edwardes-Jones, Investor at
BGF discuss how long-term funding relationship unlocks the potential of Elasmogen’s next-generation soloMER drugs.
#timeslifesciencessummit #lifesciences
Tom Whipple speaks with Georgios Leontidis and Professor Noor Shaker about accelerating drug discovery with the power of artificial intelligence.
Using AI can advance product to market, optimise clinical trials and open up drug pathways.
#timeslifesciencessummit #lifesciences
Deborah O'Neil discusses with Tom Whipple the routes to market, the importance of ensuring a tangible end user, embracing flexibility to abandon initial ideas lacking commercial viability and fostering a culture of creativity and innovation.
#timeslifesciencessummit #lifesciences